Cell populations enriched with breast cancer stem cells can be identified by expression of specific sets of marker proteins such as nucleostemin and aldehyde dehydrogenase-1 (ALDH-1), which are associated with maintenance and self-renewal properties [21–24], and by their CD44+/CD24-/low phenotype [21]. Here, CD44 is linked to breast carcinoma.